| Literature DB >> 31878148 |
Kyunghun Min1, Shamoon Naseem1, James B Konopka1.
Abstract
N-acetylglucosamine (GlcNAc) is being increasingly recognized for its ability to stimulate cell signaling. This amino sugar is best known as a component of cell wall peptidoglycan in bacteria, cell wall chitin in fungi and parasites, exoskeletons of arthropods, and the extracellular matrix of animal cells. In addition to these structural roles, GlcNAc is now known to stimulate morphological and stress responses in a wide range of organisms. In fungi, the model organisms Saccharomyces cerevisiae and Schizosaccharomyces pombe lack the ability to respond to GlcNAc or catabolize it, so studies with the human pathogen Candida albicans have been providing new insights into the ability of GlcNAc to stimulate cellular responses. GlcNAc potently induces C. albicans to transition from budding to filamentous hyphal growth. It also promotes an epigenetic switch from White to Opaque cells, which differ in morphology, metabolism, and virulence properties. These studies have led to new discoveries, such as the identification of the first eukaryotic GlcNAc transporter. Other results have shown that GlcNAc can induce signaling in C. albicans in two ways. One is to act as a signaling molecule independent of its catabolism, and the other is that its catabolism can cause the alkalinization of the extracellular environment, which provides an additional stimulus to form hyphae. GlcNAc also induces the expression of virulence genes in the C. albicans, indicating it can influence pathogenesis. Therefore, this review will describe the recent advances in understanding the role of GlcNAc signaling pathways in regulating C. albicans morphogenesis and virulence.Entities:
Keywords: Candida albicans; DAC1; GlcNAc; HXK1; N-acetylglucosamine; NAG1; NGT1; hyphal morphogenesis
Year: 2019 PMID: 31878148 PMCID: PMC7151181 DOI: 10.3390/jof6010008
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Figure 1GlcNAc metabolic pathways in Candida albicans. Catabolic proteins are indicated in red and anabolic proteins are indicated in green. Arrows indicate the direction of the biochemical activity. GlcNAc is transported into the cell by Ngt1 and then phosphorylated by Hxk1. It can then be converted into fructose-6-PO4 and metabolized. Alternatively, GlcNAc-6-PO4 can enter the anabolic pathway and be converted into UDP-GlcNAc, a key building block of cell wall chitin, GPI-anchors on proteins, and N-glycosylation of proteins. Note that cells only synthesize GlcNAc-6-PO4 so the presence of non-phosphorylated GlcNAc can act as a unique signal for the presence of exogenous GlcNAc.
Figure 2GlcNAc induction of filamentous hyphal morphology. Budding cells were grown in synthetic glucose medium to observe the yeast form, and then switched to medium containing 50 mM GlcNAc for 3 h at 37 °C to induce the transition to filamentous pseudohyphae (distinguished by pinched bud necks) and hyphal cells (chains of elongated cells with smooth parallel walls). Bars: 10 µm.
Figure 3Signal transduction pathways activated by GlcNAc. GlcNAc induces a pathway that acts through the Ngs1 and Rep1 transcription factors to induce the GlcNAc catabolic genes. It also induces a cAMP-independent pathway to stimulate hyphal growth (dashed line). These pathways do not require metabolism of GlcNAc. However, if GlcNAc is catabolized it makes the extracellular environment more alkaline, which activates signaling through the Rim101 pathway that synergizes with GlcNAc to stimulate hyphal morphogenesis and gene induction. The wavy green line in the plasma membrane indicates the pH sensing complex. Lines with an arrowhead indicate activation and lines with a blunt tip indicate negative regulation.